Larry Marton

Dr. Marton serves as a consultant to industry and to nonprofit, government, and academic institutions.In the nonprofit sector, Dr. Marton serves on the Board of Trustees of theAmerican Association for Cancer Research Foundation and on the Board of Directors of Cancer Commons.

In the for-profit sector, he serves on the Board of Directors of Cell sonics, Dategra, Matternet, Microsonic Systems, Nanotics, Omniox (also serving as Executive Chair), Renovo Rx, and xCures; is Chair of the Scientific Advisory Board of PharmaJet;is an advisor to Assurance Health Data, Citizen, Enable Medicine, Immunai, and the Precision Medicine World Conference; and is on the Editorial Board of the Journal of Precision Medicine.

Previously, Dr. Marton was Dean of the University of Wisconsin Medical School and Chaired the Departmentof Laboratory Medicine at UCSF, where he was a Professor in the Departments ofLaboratory Medicine and Neurological Surgery. Dr. Marton received his MD from the Albert Einstein College of Medicine.